دورية أكاديمية

Serum levels of miR-126 and miR-223 and outcomes in chronic kidney disease patients

التفاصيل البيبلوغرافية
العنوان: Serum levels of miR-126 and miR-223 and outcomes in chronic kidney disease patients
المؤلفون: Fourdinier, Ophélie, Schepers, Eva, Metzinger-Le Meuth, Valérie, Glorieux, Griet, Liabeuf, Sophie, Verbeke, Francis, Vanholder, Raymond, Brigant, Benjamin, Pletinck, Anneleen, Diouf, Momar, Burtey, Stéphane, Choukroun, Gabriel, Massy, Ziad A., Metzinger, Laurent, Argiles, Angel, Beige, Joachim, Brunet, Philippe, Cohen, Gerald, Deif, Omar Abou, Evenepoel, Pieter, Fliser, Danilo, Fridolin, Ivo, Gmerek, Andreas, Jankowski, Joachim, Jankowski, Vera, Masereeuw, Roos, Mischak, Harald, Ortiz, Alberto, Perna, Alessandra, Rodriguez-Portillo, Juan Mariano, Schanstra, Joost, Spasovski, Goce, Stamatialis, Dimitrios, Steppan, Sonja, Storr, Markus, Stegmayr, Bernd G., Stenvinkel, Peter, Thornalley, Paul J., Wiecek, Andrej
المساهمون: Fourdinier, Ophélie, Schepers, Eva, Metzinger-Le Meuth, Valérie, Glorieux, Griet, Liabeuf, Sophie, Verbeke, Franci, Vanholder, Raymond, Brigant, Benjamin, Pletinck, Anneleen, Diouf, Momar, Burtey, Stéphane, Choukroun, Gabriel, Massy, Ziad A., Metzinger, Laurent, Argiles, Angel, Beige, Joachim, Brunet, Philippe, Cohen, Gerald, Deif, Omar Abou, Evenepoel, Pieter, Fliser, Danilo, Fridolin, Ivo, Gmerek, Andrea, Jankowski, Joachim, Jankowski, Vera, Masereeuw, Roo, Mischak, Harald, Ortiz, Alberto, Perna, Alessandra, Rodriguez-Portillo, Juan Mariano, Schanstra, Joost, Spasovski, Goce, Stamatialis, Dimitrio, Steppan, Sonja, Storr, Marku, Stegmayr, Bernd G., Stenvinkel, Peter, Thornalley, Paul J., Wiecek, Andrej
بيانات النشر: NATURE PUBLISHING GROUP
LONDON
MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
سنة النشر: 2019
المجموعة: Università degli Studi della Campania "Luigi Vanvitelli": CINECA IRIS V:
مصطلحات موضوعية: Multidisciplinary
الوصف: Several microRNAs (miRNAs) have been linked to chronic kidney disease (CKD) mortality, cardiovascular (CV) complications and kidney disease progression. However, their association with clinical outcomes remains poorly evaluated. We used real-time qPCR to measure serum levels of miR-126 and miR-223 in a large cohort of 601 CKD patients (CKD stage G1 to G5 patients or on renal replacement therapy -CKD G5D) from Ghent University Hospital and 31 healthy controls. All-cause mortality and cardiovascular and renal events were registered as endpoints over a 6 year follow-up period. miR-126 levels were significantly lower from CKD stage G2 on, compared to controls. The serum levels of miR-223 were significantly lower from CKD stage G3B on. When considering overall mortality, patients with levels of either miR-126 or miR-223 below the median had a lower survival rate. Similar results were observed for CV and renal events. The observed link between the two miRNAs' seric levels and mortality, cardiovascular events or renal events in CKD appears to depend on eGFR. However, this does not preclude their potential role in the pathophysiology of CKD. In conclusion, CKD is associated with a decrease in circulating miR-223 and miR-126 levels.
نوع الوثيقة: article in journal/newspaper
اللغة: English
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/30872798; info:eu-repo/semantics/altIdentifier/wos/WOS:000461151800061; volume:9; issue:1; firstpage:4477; journal:SCIENTIFIC REPORTS; http://hdl.handle.net/11591/405261Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85062959371; www.nature.com/srep/index.html
DOI: 10.1038/s41598-019-41101-8
الإتاحة: https://doi.org/10.1038/s41598-019-41101-8Test
http://hdl.handle.net/11591/405261Test
رقم الانضمام: edsbas.4FAE14AE
قاعدة البيانات: BASE